Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Segel lab at Harvard’s Department of Stem Cell and Regenerative Biology (https://hscrb.harvard.edu/labs/segel-lab/ ) explores the biology of aging through the lens of developmental timing and lifespan
-
the following qualifications: (1) completed advanced degree, (2) previous teaching experience of Coptic at all levels. Previous publications are desirable, but not required. Contact Information: Applicants may
-
addition to carrying out bench research using electrophysiological recording, the successful candidate will be expected to help develop data management software for managing and analyzing large volumes
-
. Deadline: March 24, 2026. For further information regarding fields of study and the structure of the program, visit the History and Literature website at http://histlit.fas.harvard.edu. Contact Email histlit
-
computational approaches. See our lab web page (https://projects.iq.harvard.edu/gaudetlab ) for more information about our publications and research interests. Basic Qualifications Candidate must hold a PhD in
-
on performance. Please take a look at the type of work Prof. Stantcheva does on her website: https://www.stefanie-stantcheva.com/ as well as on her Social Economics Lab website http://socialeconomicslab.org
-
and Benefits This position is salaried and benefits eligible. Information regarding postdoctoral fellow salary, which is determined by the number of years post PhD, and benefits can be found at https
-
Salary Range This position is salaried and benefits eligible. Information regarding postdoctoral fellow salary, which is determined by the number of years post PhD, and benefits can be found at https
-
. Further information can be found at https://postdoc.hms.harvard.edu/guidelines . Minimum Number of References Required 2 Maximum Number of References Allowed Keywords
-
econometric methods to administrative and other large-scale datasets—particularly claims data—to support policy-relevant research on competition and regulation in the U.S. pharmaceutical market